Navigation Links
H1N1 Flu Vaccine May Shield Against 1918 Strain
Date:6/16/2010

Mouse studies suggest shot would do double duty, in unlikely event of older virus' return

WEDNESDAY, June 16 (HealthDay News) -- The H1N1 influenza vaccine distributed in 2009 also appears to protect against the 1918 Spanish influenza virus killed more than 50 million people nearly a century ago, new research in mice reveals.

The finding stems from work funded by the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, which examined the vaccine's efficacy in influenza protection among mice.

"While the reconstruction of the formerly extinct Spanish influenza virus was important in helping study other pandemic viruses, it raised some concerns about an accidental lab release or its use as a bioterrorist agent," study author Adolfo Garcia-Sastre, a professor of microbiology at the Mount Sinai School of Medicine in New York City, said in a school news release. "Our research shows that the 2009 H1N1 influenza vaccine protects against the Spanish influenza virus, an important breakthrough in preventing another devastating pandemic like 1918."

Garcia-Sastre and his colleagues report their findings in the current issue of Nature Communications.

The authors worked with three groups of mice, injecting them with either the 2009 H1N1 influenza vaccine, a seasonal influenza vaccine, or no vaccine.

Three weeks following vaccination, all the mice were exposed to a deadly dosage of the 1918 Spanish influenza virus. The researchers observed that only mice from the group that had been inoculated with the 2009 H1N1 vaccine were able to survive, although some from that group also succumbed to the Spanish influenza exposure.

In a second round of testing, Garcia-Sastre's team also injected mice with blood serum drawn from people who had been vaccinated against H1N1, and then exposed them to the Spanish influenza virus. In this way, the researchers found that antibodies present in human blood exposed to the H1N1 vaccine may also offer some protection against Spanish influenza.

"Considering the millions of people who have already been vaccinated against 2009 H1N1 influenza, cross-protection against the 1918 influenza virus may be widespread," said Garcia-Sastre. "Our research indicates that people who were exposed to the virus may also be protected. We look forward to conducting further research on the benefits of the 2009 H1N1 influenza vaccine in protecting against the deadly 1918 Spanish influenza virus."

More information

Find out more about the 1918 flu epidemic from Stanford University.



-- Alan Mozes



SOURCE: Nature Communications, June 15, 2010, news release


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. NIH-funded scientists find 2009 H1N1 pandemic influenza vaccine protects mice from 1918 flu virus
2. One-Third of U.S. Girls Get HPV Vaccine
3. One-third of young girls get HPV vaccine to prevent cervical cancer
4. Prostate Cancer Vaccine Shows Few Side Effects
5. Breast Cancer Vaccine Possible, Scientists Say
6. Vaccine hope for skin cancer sufferers
7. Mount Sinai researchers move closer to a universal influenza vaccine
8. A new cancer vaccine starves tumors of blood
9. Experimental Vaccine Shields Monkeys Against Ebola
10. Smallpox Vaccine May Protect Against HIV
11. Doctors Can Use Rotavirus Vaccine Again: FDA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
H1N1 Flu Vaccine May Shield Against 1918 Strain
(Date:12/9/2016)... ... 2016 , ... "I had a terrible time trying to get my grandson ... if the nebulizer had a more child-friendly design, then children would be more likely ... patent-pending NEBY to avoid the need to deliver medication via a nebulizer mask. The ...
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... Virginia (PRWEB) , ... December 08, 2016 , ... ... services company offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care ... operations and general counsel and Eric Hoessel to vice president of sales. ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... , Dec. 9, 2016   Hudes Laser ... December featuring the multi-wavelength Astanza Trinity laser and ... specializes in laser tattoo removal, IPL hair removal, ... ultrasound therapy. Hudes Laser Aesthetica is setting high ... and promises to deliver effective, long-lasting ...
(Date:12/9/2016)... 2016 Mitsubishi Tanabe Pharma Corporation (Head Office: ... CEO: Dr. Masayuki Mitsuka ) has presented data ... edaravone intravenously in 10-14 day cycles for 48 weeks ... ALS Functional Rating Scale-Revised (ALSFRS-R). The data were presented ... in Dublin, Ireland . ...
(Date:12/9/2016)... , Dec. 9, 2016  Axovant Sciences ... clinical-stage biopharmaceutical company focused on the treatment of ... data from a Phase 2b trial evaluating treatment ... donepezil, compared with donepezil plus placebo in people ... the addition of intepirdine to treatment was associated ...
Breaking Medicine Technology: